By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ra Pharma  

One Kendall Square
Building 1400 West, 3rd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-401-4060 Fax: 617-401-4061


Key Statistics

Ownership: Public

Web Site: Ra Pharma
Symbol: RARX

Company News
Ra Pharma (RARX) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/30/2016 11:08:50 AM
Ra Pharma (RARX) Receives Orphan Drug Designation In The European Union For RA101495 For Treatment Of Paroxysmal Nocturnal Hemoglobinuria 11/17/2016 11:30:53 AM
Ra Pharma (RARX)'s $92 Million Debut is the Ninth Massachusetts Biotech IPO of 2016 10/27/2016 6:29:55 AM
Ra Pharma Announces Pricing Of Initial Public Offering 10/26/2016 10:16:02 AM
Massachusetts VC-Backed Biotech Ra Pharma Files for $86 Million IPO 10/3/2016 6:06:48 AM
Ra Pharma Presents Clinical Data On Complement C5 Inhibitor RA101495 At The 21st Congress Of The European Hematology Association 6/10/2016 8:02:04 AM
Ra Pharma To Present At The 21st Congress Of The European Hematology Association 5/19/2016 12:15:38 PM
Ra Pharma To Present At The Jefferies 2016 Complement Therapeutics Summit 4/26/2016 11:53:44 AM
Ra Pharma Appoints Chief Scientific Officer And Expands Board Of Directors 4/6/2016 9:34:00 AM
Ra Pharma To Present At The Cowen and Company 36th Annual Health Care Conference 3/1/2016 12:50:33 PM